US Stock MarketDetailed Quotes

AKBA Akebia Therapeutics

Watchlist

1.7944
+0.0344+1.95%

Trading Dec 19 10:49 ET

391.50MMarket Cap-8.16P/E (TTM)

Akebia Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

6.59%-6.7M

-377.38%-10.07M

-10.80%-19.43M

68.03%-23.38M

95.78%-2.31M

-121.20%-7.17M

111.84%3.63M

18.88%-17.54M

71.08%-73.15M

12.94%-54.68M

Net income from continuing operations

-38.30%-20.04M

23.20%-8.58M

33.08%-17.99M

44.89%-51.93M

110.11%614K

73.22%-14.49M

-139.40%-11.17M

56.94%-26.88M

66.59%-94.23M

91.31%-6.07M

Operating gains losses

--856K

---2.33M

--423K

-16.21%-760K

----

-9.00%-654K

--0

Depreciation and amortization

-0.35%9.37M

0.03%9.41M

-0.36%9.38M

-0.19%37.63M

-0.16%9.4M

-0.18%9.41M

-0.20%9.41M

-0.72%37.7M

-0.36%9.42M

Other non cash items

1,961.48%7.78M

305.84%2.54M

238.79%952K

102.40%1.5M

103.78%2.87M

-102.86%-418K

45.15%-1.23M

-69.85%281K

-264.98%-62.62M

-552.15%-75.91M

Change In working capital

-82.00%-7.66M

-576.86%-13.64M

-376.92%-15.15M

-1,336.38%-20.73M

-200.28%-16.21M

-107.27%-4.21M

103.80%2.86M

-114.93%-3.18M

98.63%-1.44M

82.94%-5.4M

-Change in receivables

20.36%-2.41M

-273.96%-3.15M

-41.21%12.67M

-91.20%994K

1.86%-16.7M

-105.14%-3.02M

94.97%-841K

257.24%21.55M

147.02%11.3M

-1,329.83%-17.02M

-Change in inventory

65.72%-545K

-528.78%-14.93M

-160.35%-4.43M

-113.32%-2.54M

-148.18%-11.78M

-58.52%-1.59M

293.33%3.48M

240.02%7.35M

176.51%19.09M

136.59%24.45M

-Change in prepaid assets

134.12%5.52M

-142.48%-130K

-80.86%1.41M

1,019.00%11.84M

120.55%1.8M

-74.46%2.36M

103.62%306K

-18.19%7.38M

105.67%1.06M

-237.38%-8.74M

-Change in payables and accrued expense

-177.38%-6.16M

171.35%7.29M

33.94%-22.55M

58.18%-15.27M

235.39%8.22M

174.49%7.96M

110.61%2.69M

-1,063.98%-34.13M

-7.95%-36.5M

107.21%2.45M

-Change in other current assets

107.53%173K

134.76%1.07M

78.20%-613K

75.80%-1.36M

125.56%6.81M

-120.86%-2.3M

-145.63%-3.06M

-185.29%-2.81M

31.54%-5.62M

-105.95%-26.65M

-Change in other current liabilities

44.27%-4.24M

-1,167.35%-3.11M

-290.44%-2.33M

-332.21%-10.65M

-125.83%-4.56M

-35.19%-7.61M

106.01%291K

147.53%1.22M

105.83%4.59M

1,570.17%17.64M

-Change in other working capital

----

118.59%695K

-180.32%-3.74M

--0

-111.19%-3.74M

155.57%4.65M

293.66%2.47M

Cash from discontinued investing activities

Operating cash flow

6.59%-6.7M

-377.38%-10.07M

-10.80%-19.43M

68.03%-23.38M

95.78%-2.31M

-121.20%-7.17M

111.84%3.63M

18.88%-17.54M

71.08%-73.15M

12.94%-54.68M

Investing cash flow

Cash flow from continuing investing activities

-2K

-100.29%-114K

Net PPE purchase and sale

---2K

----

--0

----

-93.22%-114K

--0

Cash from discontinued investing activities

Investing cash flow

---2K

---29K

--0

-100.29%-114K

--0

Financing cash flow

Cash flow from continuing financing activities

2,346.00%1.22M

195.50%7.64M

215.71%18.48M

-272.67%-25.21M

-128,900.00%-1.29M

100.15%50K

-88,788.89%-8M

-133.58%-15.97M

-89.08%14.6M

-100.02%-1K

Net issuance payments of debt

--0

195.33%7.63M

101.71%274K

3.03%-32M

---8M

--0

---8M

---16M

---33M

--0

Net common stock issuance

3,390.00%1.75M

--750K

53,017.65%18.06M

-9.80%6.79M

671,000.00%6.71M

-20.63%50K

--0

-99.55%34K

-91.53%7.53M

-100.02%-1K

Proceeds from stock option exercised by employees

--0

--14K

--141K

-98.51%1K

--1K

--0

--67K

--0

Net other financing activities

---522K

----

-10.68%40M

--0

Cash from discontinued financing activities

Financing cash flow

2,346.00%1.22M

195.50%7.64M

215.71%18.48M

-272.67%-25.21M

-128,900.00%-1.29M

100.15%50K

-88,788.89%-8M

-133.58%-15.97M

-89.08%14.6M

-100.02%-1K

Net cash flow

Beginning cash position

-25.55%41.17M

-26.89%43.62M

-52.15%44.58M

-38.64%93.17M

-67.41%48.18M

-62.38%55.29M

-66.41%59.67M

-38.64%93.17M

-34.31%151.84M

-29.34%147.85M

Current changes in cash

23.09%-5.47M

43.83%-2.46M

97.14%-957K

17.18%-48.59M

93.42%-3.6M

-919.93%-7.12M

85.75%-4.37M

-229.81%-33.5M

26.01%-58.67M

4.75%-54.68M

End cash Position

-25.91%35.69M

-25.55%41.17M

-26.89%43.62M

-52.15%44.58M

-67.41%48.18M

-62.38%55.29M

-66.41%59.67M

-38.64%93.17M

Free cash flow

6.56%-6.7M

-378.18%-10.1M

-10.80%-19.43M

68.08%-23.38M

95.78%-2.31M

-121.20%-7.17M

111.84%3.63M

19.31%-17.54M

71.04%-73.27M

12.94%-54.68M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	6.59%-6.7M	-377.38%-10.07M	-10.80%-19.43M	68.03%-23.38M	95.78%-2.31M	-121.20%-7.17M	111.84%3.63M	18.88%-17.54M	71.08%-73.15M	12.94%-54.68M
Net income from continuing operations	-38.30%-20.04M	23.20%-8.58M	33.08%-17.99M	44.89%-51.93M	110.11%614K	73.22%-14.49M	-139.40%-11.17M	56.94%-26.88M	66.59%-94.23M	91.31%-6.07M
Operating gains losses	--856K	---2.33M	--423K	-16.21%-760K	----	----	----	----	-9.00%-654K	--0
Depreciation and amortization	-0.35%9.37M	0.03%9.41M	-0.36%9.38M	-0.19%37.63M	-0.16%9.4M	-0.18%9.41M	-0.20%9.41M	-0.20%9.41M	-0.72%37.7M	-0.36%9.42M
Other non cash items	1,961.48%7.78M	305.84%2.54M	238.79%952K	102.40%1.5M	103.78%2.87M	-102.86%-418K	45.15%-1.23M	-69.85%281K	-264.98%-62.62M	-552.15%-75.91M
Change In working capital	-82.00%-7.66M	-576.86%-13.64M	-376.92%-15.15M	-1,336.38%-20.73M	-200.28%-16.21M	-107.27%-4.21M	103.80%2.86M	-114.93%-3.18M	98.63%-1.44M	82.94%-5.4M
-Change in receivables	20.36%-2.41M	-273.96%-3.15M	-41.21%12.67M	-91.20%994K	1.86%-16.7M	-105.14%-3.02M	94.97%-841K	257.24%21.55M	147.02%11.3M	-1,329.83%-17.02M
-Change in inventory	65.72%-545K	-528.78%-14.93M	-160.35%-4.43M	-113.32%-2.54M	-148.18%-11.78M	-58.52%-1.59M	293.33%3.48M	240.02%7.35M	176.51%19.09M	136.59%24.45M
-Change in prepaid assets	134.12%5.52M	-142.48%-130K	-80.86%1.41M	1,019.00%11.84M	120.55%1.8M	-74.46%2.36M	103.62%306K	-18.19%7.38M	105.67%1.06M	-237.38%-8.74M
-Change in payables and accrued expense	-177.38%-6.16M	171.35%7.29M	33.94%-22.55M	58.18%-15.27M	235.39%8.22M	174.49%7.96M	110.61%2.69M	-1,063.98%-34.13M	-7.95%-36.5M	107.21%2.45M
-Change in other current assets	107.53%173K	134.76%1.07M	78.20%-613K	75.80%-1.36M	125.56%6.81M	-120.86%-2.3M	-145.63%-3.06M	-185.29%-2.81M	31.54%-5.62M	-105.95%-26.65M
-Change in other current liabilities	44.27%-4.24M	-1,167.35%-3.11M	-290.44%-2.33M	-332.21%-10.65M	-125.83%-4.56M	-35.19%-7.61M	106.01%291K	147.53%1.22M	105.83%4.59M	1,570.17%17.64M
-Change in other working capital	----	----	118.59%695K	-180.32%-3.74M	--0	--0	--0	-111.19%-3.74M	155.57%4.65M	293.66%2.47M
Cash from discontinued investing activities
Operating cash flow	6.59%-6.7M	-377.38%-10.07M	-10.80%-19.43M	68.03%-23.38M	95.78%-2.31M	-121.20%-7.17M	111.84%3.63M	18.88%-17.54M	71.08%-73.15M	12.94%-54.68M
Investing cash flow
Cash flow from continuing investing activities	-2K			0	0	0			-100.29%-114K	0
Net PPE purchase and sale	---2K	----	----	--0	--0	--0	----	----	-93.22%-114K	--0
Cash from discontinued investing activities
Investing cash flow	---2K	---29K	--0	--0	--0	--0	--0	--0	-100.29%-114K	--0
Financing cash flow
Cash flow from continuing financing activities	2,346.00%1.22M	195.50%7.64M	215.71%18.48M	-272.67%-25.21M	-128,900.00%-1.29M	100.15%50K	-88,788.89%-8M	-133.58%-15.97M	-89.08%14.6M	-100.02%-1K
Net issuance payments of debt	--0	195.33%7.63M	101.71%274K	3.03%-32M	---8M	--0	---8M	---16M	---33M	--0
Net common stock issuance	3,390.00%1.75M	--750K	53,017.65%18.06M	-9.80%6.79M	671,000.00%6.71M	-20.63%50K	--0	-99.55%34K	-91.53%7.53M	-100.02%-1K
Proceeds from stock option exercised by employees	--0	--14K	--141K	-98.51%1K	--1K	--0	--0	--0	--67K	--0
Net other financing activities	---522K	----	----	----	----	----	----	----	-10.68%40M	--0
Cash from discontinued financing activities
Financing cash flow	2,346.00%1.22M	195.50%7.64M	215.71%18.48M	-272.67%-25.21M	-128,900.00%-1.29M	100.15%50K	-88,788.89%-8M	-133.58%-15.97M	-89.08%14.6M	-100.02%-1K
Net cash flow
Beginning cash position	-25.55%41.17M	-26.89%43.62M	-52.15%44.58M	-38.64%93.17M	-67.41%48.18M	-62.38%55.29M	-66.41%59.67M	-38.64%93.17M	-34.31%151.84M	-29.34%147.85M
Current changes in cash	23.09%-5.47M	43.83%-2.46M	97.14%-957K	17.18%-48.59M	93.42%-3.6M	-919.93%-7.12M	85.75%-4.37M	-229.81%-33.5M	26.01%-58.67M	4.75%-54.68M
End cash Position	-25.91%35.69M	-25.55%41.17M	-26.89%43.62M	-52.15%44.58M	-52.15%44.58M	-67.41%48.18M	-62.38%55.29M	-66.41%59.67M	-38.64%93.17M	-38.64%93.17M
Free cash flow	6.56%-6.7M	-378.18%-10.1M	-10.80%-19.43M	68.08%-23.38M	95.78%-2.31M	-121.20%-7.17M	111.84%3.63M	19.31%-17.54M	71.04%-73.27M	12.94%-54.68M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	--	--

Heat List

Overall

No Data